🫀 5 key compounds

Cardiovascular & Metabolic Peptides

Cardiovascular and metabolic peptides regulate heart function, blood pressure, vascular tone, and systemic metabolic homeostasis. This category includes endogenous cardiac hormones used as clinical biomarkers as well as emerging therapeutic targets.

CardiacBlood PressureVasoactiveMetabolic SyndromeEndocrine
5
Key compounds documented
ANP
First isolated compound (1981)
Heart
Primary target organ
Clinical
Diagnostic & therapeutic use

Overview

Cardiovascular peptides are endogenous molecules that regulate the heart, vasculature, and fluid homeostasis. Many were discovered through basic cardiac physiology research and have since become critical clinical biomarkers and therapeutic targets.

Natriuretic peptides — Atrial Natriuretic Peptide (ANP) and B-type Natriuretic Peptide (BNP) — are released by cardiac muscle in response to wall stress. They promote diuresis, natriuresis, and vasodilation, acting as the heart's own protective system against volume overload. BNP (and its precursor NT-proBNP) is now a gold-standard biomarker for heart failure diagnosis.

Angiotensin 1-7, formed from angiotensin II by the ACE2 enzyme, represents the counter-regulatory arm of the renin-angiotensin system. It opposes the vasoconstrictive, pro-inflammatory effects of angiotensin II and has become a significant research target for hypertension, heart failure, and metabolic syndrome.

Key Compounds

Atrial Natriuretic Peptide (ANP)

Cardiac hormone

Released by atrial cardiomyocytes in response to stretch. Promotes diuresis, natriuresis, and vasodilation. Key regulator of blood pressure and extracellular fluid volume.

DiuresisVasodilationBlood pressure

BNP / NT-proBNP

Clinical biomarker

Ventricular-derived natriuretic peptide. FDA-approved biomarker for heart failure diagnosis, prognosis, and therapy monitoring. Synthetic BNP (nesiritide) used therapeutically.

Heart failure markerNatriuresisClinical use

Angiotensin 1-7

RAS peptide

Counter-regulatory peptide of the renin-angiotensin system, formed by ACE2 cleavage of angiotensin II. Vasodilatory, anti-fibrotic, anti-inflammatory. Studied for hypertension and metabolic syndrome.

VasodilatoryAnti-fibroticACE2 axis

Apelin

Vasoactive

Endogenous ligand of the APJ receptor. Inotropic cardiac peptide that reduces blood pressure, improves cardiac output, and has been studied in heart failure and pulmonary arterial hypertension.

InotropicVasodilatoryHeart failure

Glucagon

Pancreatic hormone

Pancreatic alpha-cell peptide that raises blood glucose, promotes hepatic glycogenolysis, and in pharmacological doses has positive inotropic cardiac effects. Studied in beta-blocker overdose management.

GlycogenolysisCardiac inotropeGlucoregulation

Mechanism of Action

1

Natriuretic Receptor Activation

ANP and BNP bind guanylyl cyclase-coupled receptors (NPR-A), increasing intracellular cGMP and promoting renal sodium excretion, vasodilation, and suppression of the renin-aldosterone axis.

2

ACE2/Angiotensin 1-7/Mas Axis

Angiotensin 1-7 acts on the Mas receptor to oppose angiotensin II effects: vasodilation, reduced inflammation, improved endothelial function, and anti-fibrotic signalling.

3

APJ Receptor Signalling

Apelin activates the APJ G-protein coupled receptor, enhancing cardiac contractility and reducing peripheral vascular resistance through NO-independent and PI3K/Akt pathways.

4

cGMP-Mediated Vasodilation

Multiple cardiovascular peptides elevate vascular smooth muscle cGMP levels, activating protein kinase G to induce relaxation and reduce blood pressure.

Research Applications

🫀

Heart Failure Research

Natriuretic peptides as diagnostic biomarkers and therapeutic targets in acute and chronic heart failure.

🩸

Hypertension Studies

Investigating ACE2/Ang 1-7 axis and natriuretic peptide pathways as antihypertensive strategies.

🔬

Metabolic Syndrome Research

Cardiovascular-metabolic intersection: studying how vasoactive peptides influence insulin sensitivity and lipid metabolism.

💊

Biomarker Development

Validating cardiac peptides as diagnostic and prognostic biomarkers for cardiovascular risk stratification.

Frequently Asked Questions

Why is BNP used as a diagnostic marker for heart failure?
B-type Natriuretic Peptide (BNP) and its precursor NT-proBNP are released by ventricular cardiomyocytes in proportion to wall stress and volume overload. Their blood levels correlate strongly with the severity of heart failure, making them sensitive and specific biomarkers for diagnosis, prognosis, and monitoring treatment response. They are now standard of care in heart failure evaluation.
What is the ACE2/Angiotensin 1-7 axis and why is it important?
ACE2 cleaves angiotensin II into Angiotensin 1-7, which then acts on the Mas receptor to oppose the effects of angiotensin II. This counter-regulatory axis promotes vasodilation, reduces oxidative stress, decreases inflammation, and has anti-fibrotic effects. It gained global prominence during the COVID-19 pandemic as ACE2 is the receptor used by SARS-CoV-2 for cell entry.
How does Apelin improve cardiac function in heart failure?
Apelin acts on the APJ receptor in the heart and vasculature. It increases cardiac contractility (positive inotrope) while simultaneously reducing peripheral vascular resistance (afterload). Unlike many inotropes, it does not increase heart rate or myocardial oxygen demand proportionally. Apelin levels decline in chronic heart failure, making it a potential therapeutic target.
What is glucagon's role beyond raising blood sugar?
Glucagon's primary role is hepatic glycogenolysis — raising blood glucose when levels fall. However, at pharmacological doses, glucagon also has positive inotropic and chronotropic cardiac effects via glucagon receptors on the heart. This is clinically exploited in beta-blocker overdose treatment. Glucagon also promotes lipolysis and ketogenesis during fasting states.
⚠️

Research Information Only

This content is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before making any health-related decisions.